Hydrocodone Bitartrate And Acetaminophen Tablet
Product Images NDC 0245-0412

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Acetaminophen (NDC 0245-0412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Hydrocodone 01)

FDA Label Image

Chemical Structure (Hydrocodone 02)

FDA Label Image

Principal Display Panel (5 mg/325 mg Tablet Blister Pack Carton)

Principal Display Panel (5 mg/325 mg Tablet Blister Pack Carton)
Hydrocodone Bitartrate and Acetaminophen Tablets, USP, are indicated for pain relief and contain 5mg of hydrocodone and 325mg of acetaminophen per tablet. The provided medication guide is intended for patient use only. Each unit-dose tablet is not child-resistant, and care should be taken to keep them out of the reach of children. The usual dosage is one to two tablets every four to six hours, with a maximum daily dosage of eight tablets. This medication is formulated and manufactured by Upsher-Smith Laboratories in Maple Grove, M55369.*
FDA Label Image

Principal Display Panel (7.5 mg/325 mg Tablet Blister Pack Carton)

Principal Display Panel (7.5 mg/325 mg Tablet Blister Pack Carton)
Hydrocodone Bitartrate and Acetaminophen Tablets, USP are a prescription medicine used to treat moderate to severe pain. Each tablet contains 7.5 mg of Hydrocodone Bitartrate and 325 mg of Acetaminophen. The usual dosage is one tablet every four to six hours as needed for pain. The total daily dosage should not exceed one tablet. The medicine guide should be provided separately to each patient. The package is not child-resistant and intended for institutional use only. It should be dispensed in a tight, light-resistant, child-resistant container. The medicine should be stored at room temperature between 68°F to 77°F (20°C to 25°C). Manufactured by Upsher-Smith Laboratories, LLC.*
FDA Label Image

Principal Display Panel (10 mg/325 mg Tablet Blister Pack Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.